Unliganded and CMP-Neu5Ac bound structures of human α-2,6-sialyltransferase ST6Gal I at high resolution.


Journal

Journal of structural biology
ISSN: 1095-8657
Titre abrégé: J Struct Biol
Pays: United States
ID NLM: 9011206

Informations de publication

Date de publication:
01 11 2020
Historique:
received: 23 06 2020
revised: 31 08 2020
accepted: 16 09 2020
pubmed: 25 9 2020
medline: 15 10 2021
entrez: 24 9 2020
Statut: ppublish

Résumé

Sialic acid residues found as terminal monosaccharides in various types of glycan chains in cell surface glycoproteins and glycolipids have been identified as important contributors of cell-cell interactions in normal vs. abnormal cellular behavior and are pivotal in diseases such as cancers. In vertebrates, sialic acids are attached to glycan chains by a conserved subset of sialyltransferases with different enzymatic and substrate specificities. ST6Gal I is a sialyltransferase using activated CMP-sialic acids as donor substrates to catalyze the formation of a α2,6-glycosidic bond between the sialic acid residue and the acceptor disaccharide LacNAc. Understanding sialyltransferases at the molecular and structural level shed light into their function. We present here two human ST6Gal I structures, which show for the first time the enzyme in the unliganded state and with the full donor substrate CMP-Neu5Ac bound. Comparison of these structures reveal flexibility of the catalytic loop, since in the unliganded structure Tyr354 adopts a conformation seen also as an alternate conformation in the substrate bound structure. CMP-Neu5Ac is bound with the side chain at C5 of the sugar residue directed outwards at the surface of the protein. Furthermore, the exact binding mode of the sialic acid moiety of the substrate directly involves sialylmotifs L, S and III and positions the sialylmotif VS in the immediate vicinity. We also present a model for the ternary complex of ST6Gal I with both the donor and the acceptor substrates.

Identifiants

pubmed: 32971290
pii: S1047-8477(20)30201-X
doi: 10.1016/j.jsb.2020.107628
pii:
doi:

Substances chimiques

Antigens, CD 0
Monosaccharides 0
Polysaccharides 0
Sialic Acids 0
cytidine-5'-monophosphosialic acid 0
Sialyltransferases EC 2.4.99.-
ST6GAL1 protein, human EC 2.4.99.1
neolactotetraosylceramide alpha-2,3-sialyltransferase EC 2.4.99.10
N-acetyllactosaminide alpha-2,3-sialyltransferase EC 2.4.99.6
Cytidine Monophosphate F469818O25
beta-D-Galactoside alpha 2-6-Sialyltransferase EC 2.4.99.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107628

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Deborah Harrus (D)

Faculty of Biochemistry and Molecular Medicine, University of Oulu, Aapistie 7A, FI-90220 Oulu, Finland.

Anne Harduin-Lepers (A)

Université de Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.

Tuomo Glumoff (T)

Faculty of Biochemistry and Molecular Medicine, University of Oulu, Aapistie 7A, FI-90220 Oulu, Finland. Electronic address: tuomo.glumoff@oulu.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH